AARTIINDNSEAugust 4, 2023

Aarti Industries Limited

1,745words
1turns
0analyst exchanges
0executives
Key numbers — 38 extracted
rs,
August 4, 2023 To, Listing/Compliance Department BSE LTD. Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai – 400 001. BSE CODE : 524208 Dear Sir/Madam, To, Listing/Compliance Dep
rs 4
standards Excellence We continuously raise the bar of our performance to delight our stakeholders 4 About Aarti Industries Limited Overview Financial Trends ▪ Established by first generation techno
22%
ith IPRs for customized products ▪ Strategically located: In western India with proximity to ports 22% 15% ₹6,252 Cr. 5-Year Revenue CAGR (excl. termination & Shortfall income) 5-Year EBITDA CAGR
15%
PRs for customized products ▪ Strategically located: In western India with proximity to ports 22% 15% ₹6,252 Cr. 5-Year Revenue CAGR (excl. termination & Shortfall income) 5-Year EBITDA CAGR (excl
₹6,252
or customized products ▪ Strategically located: In western India with proximity to ports 22% 15% ₹6,252 Cr. 5-Year Revenue CAGR (excl. termination & Shortfall income) 5-Year EBITDA CAGR (excl. termina
3%
on & Shortfall income) Fixed Assets Gross Block for FY23 Geographical Revenue break-up (FY23) 3% 100+ Products 1,100+ Domestic & Global Customers 60+ Exporting countries 16 Manufacturing Plan
rs 60
or FY23 Geographical Revenue break-up (FY23) 3% 100+ Products 1,100+ Domestic & Global Customers 60+ Exporting countries 16 Manufacturing Plants 11 Zero Liquid Discharge Plants 6000+ Employees
25.1%
Highlights (Consolidated) and Key Updates Revenues EBITDA Profit Before Tax Profit After Tax 25.1% 18.5% (Reported) (without termination & shortfall) (Reported) (Ex termination, shortfall &
18.5%
ghts (Consolidated) and Key Updates Revenues EBITDA Profit Before Tax Profit After Tax 25.1% 18.5% (Reported) (without termination & shortfall) (Reported) (Ex termination, shortfall & Q1 phar
Rs,
rter of pharma business numbers as the scheme of arrangement was effective wef 1st July 2021 Amt in Rs, Crs. 6 Key Milestones in FY23 40+ INR 1300+ cr. • Signed a binding term-sheet with Deepak Ferti
rs. 6
of pharma business numbers as the scheme of arrangement was effective wef 1st July 2021 Amt in Rs, Crs. 6 Key Milestones in FY23 40+ INR 1300+ cr. • Signed a binding term-sheet with Deepak Fertilisers fo
INR 1300
eme of arrangement was effective wef 1st July 2021 Amt in Rs, Crs. 6 Key Milestones in FY23 40+ INR 1300+ cr. • Signed a binding term-sheet with Deepak Fertilisers for 20- year Nitric Acid offtake and s
Guidance — 3 items
On Projects
opening
• • • • • Project related to 2nd contract started seeing volume ramp up.
On Projects
opening
Key Customers 10 Innovation and R&D 2 19 State-of-the-art R&D centres at Maharashtra & Gujarat PhDs and 220+ scientists 8 Patents filed 40+ Planned product introductions, more than 50% products will be launched first time in India 18,000 sq.
On Projects
opening
2,500-3,000 crore for Chemicals ● Site development work initiated on 100+ acre land at Jhagadia ● Environmental Clearances obtained / in process ● Project works already underway ● Will drive the growth from FY25 and beyond ● End use majorly in Agrochemicals & Pharma.
Advertisement
Speaking time
On Projects
1
Opening remarks
On Projects
• • • • • Project related to 2nd contract started seeing volume ramp up. Commercialised facility for the 3rd Long Term contract at Jhagadia Commercialised two Speciality Chemical Complex at Jhagadia Announced Expansion in Nitro Toluene and Ethylation Capacities Project work under way at Zone 4 (Jhagadia) for Multi purpose plant and Chloro Toluene & Downstream related projects • Other project initiatives on track 7 Shareholders Info 8 Key Strengths Global Player in Benzene based Derivatives with Integrated Operations Top 3 In Chlorination and Nitration globally Top 2 In Hydrogenation globally Well placed to benefit from Industry Tailwinds Alternate to China & Europe Fully Backward Integrated Low-cost, sustainable manufacturing opportunities in sunrise sectors Strong Focus on R&D and Process Innovation 40+ Products in R&D pipeline Well Diversified Across Multiple Dimensions 100+ Multi-product 60+ Countries 400+ Global Customer 700+ Domestic Customer Thrust on Sustainability 45% Water rec
Advertisement
← All transcriptsAARTIIND stock page →